This IAA will support the development of standardized methods required for spiking whole blood or plasma samples for several low prevalence pathogens. These spiked samples will aid researchers in the ability to conduct clinical sensitivity studies required for FDA clearance of diagnostics for NIAID Category A-C agents.

Agency
National Institute of Health (NIH)
Type
NIH Inter-Agency Agreements (Y01)
Project #
AAI13005001-1-0-1
Application #
8807826
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2014
Total Cost
Indirect Cost
City
State
Country
Zip Code